Economic Evaluation of Recombinant Human Granulocyte Colony-Stimulating Factor in Very High-Risk Childhood Acute Lymphoblastic Leukemia

In a previous randomized study, the authors reported that granulocyte colony-stimulating factor (G-CSF) increased the chemotherapy dose-intensity delivered during the consolidation therapy of high-risk childhood acute lymphoblastic leukemia (ALL). The aim of the current study was to perform an economic evaluation in the same cohort.